SEE
38
-3
TROW
34
-5
KEY
51
-3
BIIB
37
7
UNP
40
-2
NAVI
55
-2
IP
39
-6
NTAP
60
2
AMP
66
-4
EOG
42
-8
MOS
19
-4
GOOGL
56
2
AVB
65
-2
HSY
40
2
THC
61
-3
RF
51
-2
KSS
39
6
VRSK
35
-3
STZ
63
10
ISRG
68
-3
SEE
38
-3
TROW
34
-5
KEY
51
-3
BIIB
37
7
UNP
40
-2
NAVI
55
-2
IP
39
-6
NTAP
60
2
AMP
66
-4
EOG
42
-8
MOS
19
-4
GOOGL
56
2
AVB
65
-2
HSY
40
2
THC
61
-3
RF
51
-2
KSS
39
6
VRSK
35
-3
STZ
63
10
ISRG
68
-3
Financhill
Back

Voyager Therapeutics Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21

VYGR
Voyager Therapeutics

Last Price:
6.26
Seasonality Move:
-14.28%

7 Day Trial

ALL ACCESS PASS

$ 7

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Voyager Therapeutics Price Quote

$6.26
+0.01 (+-0.95%)
(Updated: September 21, 2024 at 6:50 AM ET)

Voyager Therapeutics Key Stats

Sell
21
Voyager Therapeutics (VYGR) is a Sell
Day range:
$6.07 - $6.32
52-week range:
$5.97 - $11.72
Dividend yield:
0%
P/E ratio:
2.10
P/S ratio:
2.27
P/B ratio:
1.02%
Volume:
521.2K
Avg. volume:
403.4K
1-year change:
-18.78%
Market cap:
$340.8M
Revenue:
$250M
EPS:
$0.22

How Much Does Voyager Therapeutics Make?

Is Voyager Therapeutics Growing As A Company?

  • What Is Voyager Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 5.09%
  • What Is Voyager Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Voyager Therapeutics Stock Price Performance

What Is Voyager Therapeutics 52-Week High & Low?

Voyager Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Voyager Therapeutics?

Is Voyager Therapeutics Cash Flow Positive?

  • What Is VYGR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.6M
  • What Is Voyager Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $114.2M
  • What Is Voyager Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$263.5M

Voyager Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VYGR return on invested capital is 3.5%
  • What Is Voyager Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 2.42%
  • What Is VYGR Return On Equity?
    ROE is a measure of profitability and is 3.5%

Voyager Therapeutics Earnings Date & Stock Price

Voyager Therapeutics Competitors

Voyager Therapeutics Dividend Yield

Voyager Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.7%
Revenue: 509.48% 210.88%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 17.63
Upside from Last Price: 182%

Major Shareholders

  • How many VYGR shares are owned by institutional investors?
    50.5M VYGR shares are owned by institutional investors
  • How many VYGR shares are owned by insiders?
    2.9M VYGR shares are owned by insiders